LONG-TERM DISEASE OUTCOMES IN SYMPTOMATIC MULTIPLE MYELOMA PATIENTS: A RETROSPECTIVE ANALYSIS OF THE PHAROS REGISTRY

被引：2
|
作者：
Verelst, S. G. [1 ]
Blommestein, H. M. [2 ,3 ,4 ]
De Groot, S. [2 ,4 ]
Gonzalez-McQuire, S. [5 ]
DeCosta, L. [6 ]
de Raad, J. [7 ,8 ]
Sonneveld, P. [1 ]
Uyl-de Groot, C. A. [9 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands
[3] Comprehens Canc Org, Utrecht, Netherlands
[4] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[5] Amgen Europe GmbH, Zug, Switzerland
[6] Amgen Ltd, Uxbridge, Middx, England
[7] Amgen BV, Breda, Netherlands
[8] Univ Utrecht, Breda, Netherlands
[9] Erasmus Univ, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1537
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN204
引用
收藏
页码：A170 / A170
页数：1
相关论文
共 50 条
  • [31] THE EXPERIENCE OF LONG-TERM LENALIDOMIDE THERAPY OF PATIENTS WITH FOR MULTIPLE MYELOMA
    Samoilova, O. S.
    Grishunina, M. E.
    Rastorguev, G. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2011, 56 (03): : 40 - 42
  • [32] Toxicity of thalidomide in multiple myeloma patients (long-term observations).
    Dmoszynska, A
    Manko, J
    Jawniak, D
    Ciepluch, H
    Hellmann, A
    Wolska-Smolen, T
    Skotnicki, A
    Soroka-Wojtaszko, M
    Urbanska-Rys, H
    Konopka, L
    Hus, M
    BLOOD, 2002, 100 (11) : 387B - 387B
  • [33] Long-Term Evaluation of Bone Cementoplasty in Multiple Myeloma Patients
    Soliman, Samer
    Garderet, Laurent
    Premat, Kevin
    Allard, Julien
    Talbi, Atika
    Drir, Mehdi
    Elhorany, Mahmoud
    Hamad, Nada
    Choquet, Sylvain
    Chiaroni, pierre Marie
    Clarencon, Frederic
    Shotar, Eimad
    BLOOD, 2024, 144 : 7005 - 7006
  • [34] A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
    Munshi, Nikhil C.
    Avet-Loiseau, Herve
    Anderson, Kenneth C.
    Neri, Paola
    Paiva, Bruno
    Samur, Mehmet
    Dimopoulos, Meletios
    Kulakova, Margarita
    Lam, Annette
    Hashim, Mahmoud
    He, Jianming
    Heeg, Bart
    Ukropec, Jon
    Vermeulen, Jessica
    Cote, Sarah
    Bahlis, Nizar
    BLOOD ADVANCES, 2020, 4 (23) : 5988 - 5999
  • [35] Long-term Reversibility Analysis of Peripheral Neuropathy in Multiple Myeloma Patients Treated with Bortezomib
    Garcia Guinon, Antonio
    Escoda, Lourdes
    Ben, Randa
    Vicent, Ana
    Rivero, Eugenia
    Alex, Martinez
    Campoy, Desiree
    Abella, Eugenia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E123 - E124
  • [36] Long-term outcomes of single/tandem autologous haematopoietic progenitor cell transplantation in high-risk de novo multiple myeloma patients: a retrospective analysis
    Martino, M.
    Fedele, R.
    Console, G.
    Messina, G.
    Irrera, G.
    Callea, V.
    Piro, E.
    Musolino, C.
    Brugiatelli, M.
    Molica, S.
    Abbadessa, A.
    Morabito, F.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S150 - S150
  • [37] Long-term Outcomes of Symptomatic Gallbladder Sludge
    Lee, Yoon Suk
    Kang, Bong Kyun
    Hwang, In Kyeom
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (07) : 594 - 598
  • [38] Long-term outcomes of resection in patients with symptomatic benign liver tumours
    van Rosmalen, Belle V.
    Bieze, Matthanja
    Besselink, Marc G. H.
    Tanis, Pieter
    Verheij, Joanne
    Phoa, Saffire S. K. S.
    Busch, Olivier
    van Gulik, Thomas M.
    HPB, 2016, 18 (11) : 908 - 914
  • [39] Predicting Long-Term Outcomes in Asymptomatic or Minimally Symptomatic Patients With HCM
    Rakowski, Harry
    Li, Qin
    JACC-CARDIOVASCULAR IMAGING, 2014, 7 (01) : 37 - 39
  • [40] Heartbeat: long-term outcomes in patients with symptomatic coronary artery spasm
    Otto, Catherine M.
    HEART, 2022, 108 (16) : 1247 - 1249
12345